Administration is typically subcutaneous, with careful dosing and cycling to avoid receptor desensitization and adverse metabolic effects
Why the numbers move Because the compound class sets the pharmacology, cost differences between programs usually reflect dispensing route and packaging rather than a different drug
Circulation 140(20):16131622 Sharma A, Ambrosy AP, DeVore AD, Margulies KB, McNulty SE, Mentz RJ, Hernandez AF, Michael Felker G, Cooper LB, Lala A, Vader J, Groake JD, Borlaug BA, Velazquez EJ (2018) Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial
The pathophysiology of IC/BPS is poorly understood, and theories include chronic inflammation, autoimmune dysregulation, bacterial cystitis, urothelial dysfunction, deficiency of the glycosaminoglycan (GAG) barrier and urine cytotoxicity
The US Food and Drug Administration (FDA) approved Wegovy injections to help adults with obesity or overweight and obese adolescents aged 12 and older with their weight-related concerns
